US62856X2018 - Common Stock
MYMD PHARMACEUTICALS INC
NASDAQ:MYMD (4/19/2024, 9:51:45 AM)
2.51
-0.01 (-0.4%)
Mymd Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Baltimore, Maryland and currently employs 9 full-time employees. The company went IPO on 2008-07-24. MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The firm is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. The Company’s MYMD-1 is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company also shows potential as an anti-fibrotic and anti-prolific therapeutic. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. Supera-CBD is a synthetic, preclinical cannabidiol derivative that has been demonstrated to effectively target cannabinoid type 2 (CB2) receptors. Supera-CBD binds to and inhibits opioid receptors, comparing it side by side with plant-based cannabidiol (CBD).
MYMD PHARMACEUTICALS INC
855 N. Wolfe Street, Suite 601
Baltimore MARYLAND 08086
P: 18568488698
CEO: Christopher C. Schreiber
Employees: 9
Website: https://www.mymd.com/
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Vivos Therapeutics stock is up on Tuesday as VVOS investors react to the company securing full Medicare reimbursement for its OSA device.
Vincerx Pharma stock is falling hard on Tuesday after the company failed to impress VINC shareholders with its latest clinical trial update.
Get insights into the top gainers and losers of Tuesday's pre-market session.
MyMD Pharmaceuticals stock is rising on Tuesday as MYMD investors react to new amendment to a securities purchase agreement.
Here you can normally see the latest stock twits on MYMD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: